MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

Search

PerkinElmer Inc

Chiusa

SettoreSettore sanitario

0

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Metriche Chiave

By Trading Economics

Entrata

95M

Vendite

45M

729M

P/E

Media del settore

46

63.778

EPS

1.42

Rendimento da dividendi

0.26

Margine di Profitto

12.976

Dipendenti

11,000

EBITDA

7.4M

223M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+44.07% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.26%

2.39%

Utili prossimi

28 apr 2025

Prossima data del Dividendo

9 mag 2025

Prossima data del' Ex Dividendo

18 apr 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.9B

13B

Apertura precedente

0

Chiusura precedente

0

Notizie sul Sentiment di mercato

By Acuity

24%

76%

33 / 386 Classifica in Healthcare

PerkinElmer Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 apr 2025, 22:38 UTC

Azioni calde

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

7 apr 2025, 00:00 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Stonepeak's Total Contribution Lower Than Nominal Equity Interest Give Accelerated Spend

6 apr 2025, 23:58 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Deal 'a Material Step' Toward Readiness for Final Investment Decision

6 apr 2025, 23:58 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Deal 'Significantly Reduces' Company's Capex Profile

6 apr 2025, 23:57 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Stonepeak to Contribute 75% of Project Capex in Both 2025, 2026

6 apr 2025, 23:57 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Stonepeak to Provide $5.7 Billion Towards Expected Project Capex

6 apr 2025, 23:57 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

6 apr 2025, 23:57 UTC

Discorsi di Mercato

Nervous Start For AUD/USD; Watch on CNY Fix -- Market Talk

6 apr 2025, 23:56 UTC

Acquisizioni, Fusioni, Takeovers

Woodside Energy: Signs Deal With Stonepeak for Sale of 40% Interest in Louisiana LNG Infrastructure

6 apr 2025, 23:52 UTC

Discorsi di Mercato

Gold Slips; Likely Unwinding of Long Positions to Raise Cash -- Market Talk

6 apr 2025, 23:39 UTC

Discorsi di Mercato

Oil Futures Slide on Fears of Weakening Global Demand -- Market Talk

6 apr 2025, 23:39 UTC

Discorsi di Mercato

Nikkei May Fall as U.S. Tariffs Weigh on Global Econ Outlook -- Market Talk

6 apr 2025, 23:39 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

6 apr 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Reinsurance Relationship With MS Primary Will Continue

6 apr 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Acquisition at 53% Premium to Most Recent Share Price

6 apr 2025, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Acquisition Subject to Regulatory Approvals

6 apr 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Dai-ichi Life Acquiring Stake From MS&AD Insurance

6 apr 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Dai-ichi Life Paying About A$8.46/Share

6 apr 2025, 23:35 UTC

Acquisizioni, Fusioni, Takeovers

Challenger: Dai-ichi Life Agrees to Acquire 15.1% Interest

6 apr 2025, 21:58 UTC

Notizie principali

Bitcoin Is Falling Amid Global Market Swoon -- Barrons.com

6 apr 2025, 13:00 UTC

Notizie principali

Trump Promised to Lower Energy Prices -- But It Wasn't Supposed to Be Like This -- WSJ

5 apr 2025, 15:45 UTC

Notizie principali

Republicans Advance Trump's Tax Cuts After Late-Night Session -- Update

5 apr 2025, 15:00 UTC

Notizie principali

U.S.-Stock Funds Have a Quarter to Forget -- Journal Report

5 apr 2025, 15:00 UTC

Notizie principali

The Complicated Relationship Between Consumer Sentiment and Stocks -- Journal Report

5 apr 2025, 14:38 UTC

Notizie principali

Trump's Trade Broadside Puts Chinese Economy Under Heavy Pressure -- WSJ

5 apr 2025, 06:44 UTC

Notizie principali

Republicans Advance Trump's Tax Cuts After Late-Night Session -- WSJ

5 apr 2025, 01:00 UTC

Acquisizioni, Fusioni, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 apr 2025, 01:00 UTC

Acquisizioni, Fusioni, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 apr 2025, 21:53 UTC

Discorsi di Mercato

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 apr 2025, 21:44 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

Confronto tra pari

Modifica del prezzo

PerkinElmer Inc Previsione

Obiettivo di Prezzo

By TipRanks

44.07% in crescita

Previsioni per 12 mesi

Media 136.64 USD  44.07%

Alto 145 USD

Basso 120 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per PerkinElmer Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

11 ratings

7

Acquista

4

Mantieni

0

Vendi

Sentiment

By Acuity

33 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.